Menu
GeneBe

2-157856026-C-T

Variant summary

Our verdict is Benign. Variant got -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_001111067.4(ACVR1):c.-183+19770G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.601 in 151,508 control chromosomes in the GnomAD database, including 31,702 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.60 ( 31702 hom., cov: 29)

Consequence

ACVR1
NM_001111067.4 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -3.11
Variant links:
Genes affected
ACVR1 (HGNC:171): (activin A receptor type 1) Activins are dimeric growth and differentiation factors which belong to the transforming growth factor-beta (TGF-beta) superfamily of structurally related signaling proteins. Activins signal through a heteromeric complex of receptor serine kinases which include at least two type I ( I and IB) and two type II (II and IIB) receptors. These receptors are all transmembrane proteins, composed of a ligand-binding extracellular domain with cysteine-rich region, a transmembrane domain, and a cytoplasmic domain with predicted serine/threonine specificity. Type I receptors are essential for signaling; and type II receptors are required for binding ligands and for expression of type I receptors. Type I and II receptors form a stable complex after ligand binding, resulting in phosphorylation of type I receptors by type II receptors. This gene encodes activin A type I receptor which signals a particular transcriptional response in concert with activin type II receptors. Mutations in this gene are associated with fibrodysplasia ossificans progressive. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.92).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.762 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
ACVR1NM_001111067.4 linkuse as main transcriptc.-183+19770G>A intron_variant ENST00000434821.7

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
ACVR1ENST00000434821.7 linkuse as main transcriptc.-183+19770G>A intron_variant 1 NM_001111067.4 P4

Frequencies

GnomAD3 genomes
AF:
0.601
AC:
91056
AN:
151390
Hom.:
31704
Cov.:
29
show subpopulations
Gnomad AFR
AF:
0.230
Gnomad AMI
AF:
0.714
Gnomad AMR
AF:
0.745
Gnomad ASJ
AF:
0.735
Gnomad EAS
AF:
0.495
Gnomad SAS
AF:
0.585
Gnomad FIN
AF:
0.763
Gnomad MID
AF:
0.684
Gnomad NFE
AF:
0.768
Gnomad OTH
AF:
0.634
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.601
AC:
91061
AN:
151508
Hom.:
31702
Cov.:
29
AF XY:
0.603
AC XY:
44632
AN XY:
74048
show subpopulations
Gnomad4 AFR
AF:
0.230
Gnomad4 AMR
AF:
0.746
Gnomad4 ASJ
AF:
0.735
Gnomad4 EAS
AF:
0.495
Gnomad4 SAS
AF:
0.585
Gnomad4 FIN
AF:
0.763
Gnomad4 NFE
AF:
0.768
Gnomad4 OTH
AF:
0.629
Alfa
AF:
0.737
Hom.:
53177
Bravo
AF:
0.583
Asia WGS
AF:
0.499
AC:
1738
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.92
Cadd
Benign
0.017
Dann
Benign
0.62

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs4664901; hg19: chr2-158712538; API